Tenofovir alafenamide News

Latest Articles

• Long-Term Tenofovir Alafenamide Study Confirms Eight-Year Safety and Efficacy for Hepatitis B Patients in China

  Published: Apr 25, 2026

  Section: Medical News

  A comprehensive eight-year analysis of two Phase 3 trials reveals that Tenofovir alafenamide (TAF) maintains high viral suppression and superior bone and renal safety in Chinese pa...